The risk assessments pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 for ametoctradin and mandipropamid have not yet been finalised by the respective rapporteur Member States and additional time is required to complete the remaining steps in each renewal procedure.
Recital 27, Regulation (EU) 2025/1489
In forcesince 24 Jul 2025
- celex=32012R0844